BDBM62534 MLS000030164::N-[4-[4-(2-furoyl)piperazine-1-carbonyl]phenyl]-2-methyl-propionamide::N-[4-[4-(furan-2-carbonyl)piperazine-1-carbonyl]phenyl]-2-methylpropanamide::N-[4-[4-(furan-2-ylcarbonyl)piperazin-1-yl]carbonylphenyl]-2-methyl-propanamide::N-[4-[[4-[2-furanyl(oxo)methyl]-1-piperazinyl]-oxomethyl]phenyl]-2-methylpropanamide::N-{4-[4-(Furan-2-carbonyl)-piperazine-1-carbonyl]-phenyl}-isobutyramide::SMR000015117::cid_646366

SMILES COCn1nc2cc(N3CCOc4cc(C(=O)N5CCC(F)(F)CC5)cnc43)ccn2c1=O

InChI Key InChIKey=OXBLIIWNBNSVTH-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 62534   

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 62534BDBM62534(US12577217, Example 1-43)
Affinity DataIC50: 10nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent